In the published article, there was an error in the Funding statement. The manuscript was published without due mention of the funding agency. The correct Funding statement appears below.
“Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Portugal, ref. UID/04413/2020.”
In addition, the article was published without including the acknowledgments. The correct Acknowledgments statement appears below.
“Foundation for Science and Technology (Fundação para a Ciência e tecnologia) for funds to GHTM – UID/04413/2020”
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
tuberculosis, COVID-19, COVID-19 pandemic, end TB strategy, global health
Citation
Rosário Souza M, Silva da Paz W, dos Santos Sales VB, Hilario de Jesus GF, dos Santos Tavares D, Almeida Lima SVM, Lopes Sousa ÁF, Vieira de Melo E, Feliciano do Carmo R, Freire de Souza CD and Bezerra-Santos M (2022) Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?. Front. Pharmacol. 13:999301. doi: 10.3389/fphar.2022.999301
Received
20 July 2022
Accepted
25 July 2022
Published
06 September 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Rosário Souza, Silva da Paz, dos Santos Sales, Hilario de Jesus, dos Santos Tavares, Almeida Lima, Lopes Sousa, Vieira de Melo, Feliciano do Carmo, Freire de Souza and Bezerra-Santos.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Álvaro Francisco Lopes Sousa, sousa.alvaromd@gmail.com
This article was submitted to Drugs Outcomes Research and Policies, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.